Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure

AIMS: Associations between growth differentiation factor‐15 (GDF‐15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HFrEF) are unknown. We utilized data from the ‘Functional Impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Abhinav, Greene, Stephen, Vaduganathan, Muthiah, Fudim, Marat, Ambrosy, Andrew P., Sun, Jie‐Lena, McNulty, Steven E., Hernandez, Adrian F., Borlaug, Barry A., Velazquez, Eric J., Mentz, Robert J., DeVore, Adam D., Alhanti, Brooke, Margulies, Kenneth, Felker, G. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318489/
https://www.ncbi.nlm.nih.gov/pubmed/34061470
http://dx.doi.org/10.1002/ehf2.13348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318489/
https://www.ncbi.nlm.nih.gov/pubmed/34061470
http://dx.doi.org/10.1002/ehf2.13348

Ejemplares similares